Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling

Oncotarget

Volumn 7, Issue 28, 2016, Pages 44478-44491

  Yang, Zhao ^a   Xie, Hongjun ^a   He, Dalin ^a   Li, Lei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

AKT; EMT; Macrophage; RCC; Stem cell

Indexed keywords

INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL INVASION; CELL POPULATION; COCULTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; MACROPHAGE MIGRATION; MALE; METASTASIS; MOUSE; MOUSE MODEL; NONHUMAN; SIGNAL TRANSDUCTION; STEM CELL LIKE POPULATION; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; CANCER STEM CELL; CELL LINE; CELL MOTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; MACROPHAGE; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; RENAL CELL CARCINOMA; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, RENAL CELL; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MACROPHAGES; MALE; MICE, NUDE; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84978680807     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9873     Document Type: Article

References (39)

1. Mulders PF, Brouwers AH, Hulsbergen-van der Kaa CA, van Lin EN, Osanto S and de Mulder PH. [Guideline 'Renal cell carcinoma']. Ned Tijdschr Geneeskd. 2008; 152:376-380.
2. Ramana J. RCDB: Renal Cancer Gene Database. BMC Res Notes. 2012; 5:246.
3. Najjar YG and Rini BI. Novel agents in renal carcinoma: a reality check. Ther Adv Med Oncol. 2012; 4:183-194.
4. Staehler M, Rohrmann K, Haseke N, Stief CG and Siebels M. Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets. 2005; 6:835-846.
5. Geissler K, Fornara P, Lautenschlager C, Holzhausen HJ, Seliger B and Riemann D. Immune signature of tumor infiltrating immune cells in renal cancer. Oncoimmunology. 2015; 4:e985082.
6. Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto H, Lin WJ and Chang C. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptormediated CCL4-STAT3 signaling. Cancer research. 2013; 73:5633-5646.
7. Minárik I, Laštovicka J, Budinskỳ V, Kayserová J, Špíšek R, Jarolím L, Fialová A, Babjuk M and Bartunková J. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma. Immunology letters. 2013; 152:144-150.
8. Sica A. Role of tumour-associated macrophages in cancerrelated inflammation. Experimental oncology. 2010; 32:153-158.
9. Yhee JY, Yu CH, Kim JH, Im KS, Kim NH, Brodersen BW, Doster AR and Sur JH. Angiogenesis and expression of vascular endothelial growth factor, tumour necrosis factoralpha and hypoxia inducible factor-1alpha in canine renal cell carcinoma. Journal of comparative pathology. 2012; 147:129-138.
10. Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, Kanda S and Sakai H. High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma. International journal of clinical and experimental pathology. 2014; 7:3158-3165.
11. Santoni M, Berardi R, Amantini C, Burattini L, Santini D, Santoni G and Cascinu S. Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor. International journal of cancer Journal international du cancer. 2014; 134:2772-2777.
12. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB and Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007; 7:256-269.
13. Ksiazkiewicz M, Markiewicz A and Zaczek AJ. Epithelialmesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology. 2012; 79:195-208.
14. Molina JR, Hayashi Y, Stephens C and Georgescu MM. Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia. 2010; 12:453-463.
15. Larue L and Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24:7443-7454.
16. Liotta LA and Kohn EC. The microenvironment of the tumour-host interface. Nature. 2001; 411:375-379.
17. Hsu CW, Poche RA, Saik JE, Ali S, Wang S, Yosef N, Calderon GA, Scott L, Jr., Vadakkan TJ, Larina IV, West JL and Dickinson ME. Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules. Plos One. 2015; 10:e0131643.
18. Dannenmann SR, Thielicke J, Stockli M, Matter C, von Boehmer L, Cecconi V, Hermanns T, Hefermehl L, Schraml P, Moch H, Knuth A and van den Broek M. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. Oncoimmunology. 2013; 2:e23562.
19. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG and Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008; 453:807-811.
20. Ho MY, Tang SJ, Chuang MJ, Cha TL, Li JY, Sun GH and Sun KH. TNF-alpha induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3betadependent mechanism. Molecular cancer research: MCR. 2012; 10:1109-1119.
21. Bostrom AK, Moller C, Nilsson E, Elfving P, Axelson H and Johansson ME. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition. Human pathology. 2012; 43:708-719.
22. Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM, Rosser CJ, Su LM, Vieweg J and Kusmartsev S. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer research. 2011; 71:6400-6409.
23. Behnes CL, Bremmer F, Hemmerlein B, Strauss A, Strobel P and Radzun HJ. Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. Virchows Arch. 2014; 464:191-196.
24. Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012; 12:767-775.
25. Alison MR, Lin WR, Lim SM and Nicholson LJ. Cancer stem cells: in the line of fire. Cancer Treat Rev. 2012; 38:589-598.
26. Masui T, Ota I, Yook JI, Mikami S, Yane K, Yamanaka T and Hosoi H. Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells. Int J Oncol. 2014; 44:693-699.
27. Bessede E, Staedel C, Acuna Amador LA, Nguyen PH, Chambonnier L, Hatakeyama M, Belleannee G, Megraud F and Varon C. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene. 2014; 33:4123-4131.
28. Jordan NV, Johnson GL and Abell AN. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle. 2011; 10:2865-2873.
29. Yang J, Liao D, Chen C, Liu Y, Chuang TH, Xiang R, Markowitz D, Reisfeld RA and Luo Y. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells. 2013; 31:248-258.
30. Cancer Genome Atlas Research N. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013; 499:43-49.
31. Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH and Sabatini DM. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 2014; 4:554-563.
32. Vivanco I and Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002; 2:489-501.
33. Guo H, German P, Bai S, Barnes S, Guo W, Qi X, Lou H, Liang J, Jonasch E, Mills GB and Ding Z. The PI3K/AKT Pathway and Renal Cell Carcinoma. Journal of genetics and genomics = Yi chuan xue bao. 2015; 42:343-353.
34. Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J, Zurita AJ, Rini BI, Sharma P, Atkins MB, Walker CL and Rathmell WK. State of the science: an update on renal cell carcinoma. Molecular cancer research: MCR. 2012; 10:859-880.
35. Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, Cordon-Cardo C, Simon MC, Rafii S and PandolfiPP. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature. 2006; 442:779-785.
36. Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao YH, Chu CY, Tsai TF, Chiu HC, Dai YS, Inoue H, Yang PC, Kuo ML and Jee SH. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol. 2009; 129:1016-1025.
37. Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, Nguyen AL, Kwon CW and Le AD. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells. 2010; 28:1856-1868.
38. Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ and Chang C. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med. 2013; 5:1383-1401.
39. Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S and Chang C. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 2015; 6:14179-14190 doi: 10.18632/oncotarget.3651.